Historica vital et mortis 1622 l.jpg
This presentation is the property of its rightful owner.
Sponsored Links
1 / 137

Historica Vital et Mortis 1622 PowerPoint PPT Presentation


  • 118 Views
  • Uploaded on
  • Presentation posted in: General

“The use of tobacco… conquers men with a certain secret pleasure so that those who have once been accustomed thereto can hardly be restrained therefrom” Sir Francis Bacon. Historica Vital et Mortis 1622. Tobacco Facts.

Download Presentation

Historica Vital et Mortis 1622

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Historica vital et mortis 1622 l.jpg

“The use of tobacco…conquers men with a certain secret pleasure so that those who have once been accustomed theretocan hardly be restrained therefrom” Sir Francis Bacon

Historica Vital et Mortis 1622


Tobacco facts l.jpg

Tobacco Facts

  • #1 public health problem in the United States

  • Most preventable cause of morbidity and mortality

  • Causes more deaths each year than alcohol, motor vehicle accidents, suicide, AIDS, homicide, illicit drugs and fires combined

  • Proven risk factor for heart disease, malignant neoplasms and stroke

  • One-third of all tobacco users will die prematurely


Slide3 l.jpg

ComparativeCauses of Annual Deaths in the United States

Number of Deaths (thousands)

AIDS Alcohol Motor Homicide Drug Suicide Smoking

Vehicle Induced

Source: CDC


Impact of smoking l.jpg

Impact of Smoking

  • Smoking is now conclusively linked to acute myeloid leukemia and cancers of the cervix, kidney, pancreas and stomach

  • Smoking is now also known to cause pneumonia, abdominal aortic aneruysm, cataracts and periodontitis

  • Smoking harms nearly every organ of the body, damaging a smoker's overall health even when it does not cause a specific illness


Impact of secondhand smoke l.jpg

Impact of Secondhand Smoke

  • Many millions of Americans are still exposed to secondhand smoke

  • Secondhand smoke exposure causes disease and premature death

  • Children exposed to secondhand smoke are at an increased risk for sudden infant death syndrome (SIDS), acute respiratory infections, ear problems, and more severe asthma. respiratory symptoms and slows lung growth children

  • Exposure of adults to secondhand smoke has immediate adverse effects on the cardiovascular system and causes coronary heart disease and lung cancer

  • The scientific evidence indicates that there is no safe level of exposure to secondhand smoke

  • Eliminating smoking in indoor spaces fully protects people from exposure to secondhand smoke - separating sections, air cleaning systems, and ventilating buildings cannot eliminate the risk of exposure


Smoking statistics l.jpg

Smoking Statistics

  • About 44.5 million Americans are current smokers – 20.9%

  • 23.4% of men and 18.5% of women smoke in US

  • Prevalence

    • Native Americans & Alaskan Natives (33.4%),

    • Persons reporting two or more races (31.0%)

    • Caucasians (22.2 %)

    • African Americans (20.2 %)

    • Hispanics (15.0 %)

    • Southeast Asians (11.3 %)


Smoking incidence scope l.jpg

Smoking Incidence & Scope

  • In 2002, 17.3 percent of pregnant women aged 15 to 44 smoked cigarettes in the past month compared with 31.1 percent of nonpregnant women of the same age group.

  • The annual toll on the nation’s health and economy is staggering: 440,000 deaths, 8.6 million people suffering from at least one serious illness related to smoking,

  • $75 billion in direct medical costs; $82 billion in lost productivity.


Smoking trends l.jpg

Smoking Trends

  • Since 1974, the smoking prevalence in men has decreased by about 1% a year, in women 0.33%

  • Prevalence has remained fairly constant since 1992

  • Children raised in households where one or both parents smoke are 2 to 5 times more likely to smoke

  • 1/3 of households with children under 6 years old contains at least one smoker

  • 90% of smokers begin smoking before age 21


Tobacco is not an equal opportunity killer l.jpg

Tobacco is Not an Equal OpportunityKiller

  • Smoking affects young, the poor, depressed, uninsured, less educated, blue-collar, and minorities most in the US

  • Addiction affects those with the least information about health risks, with the fewest resources to resist advertising, and the least access to cessation services

  • Those below poverty line are >40% more likely to smoke than those above poverty line


Unequal patterns of use and exposure l.jpg

38% of persons with 9-11 yrs education

40% of cooks/truckers

1/3 of service workers covered by smoke-free policies

Social norm for low SES different from high SES

13% of persons with college degree or higher

3% of lawyers

½ of white collar workers covered by smoke-free policies

Higher SES less likely to be exposed to parent/peer smokers

Unequal Patterns of Use and Exposure


Smoking population trend lines l.jpg

Smoking Population Trend Lines

The Department of Health and Human Services has set a goal of reducing smoking

prevalence to 12% or less by 2010.


Cessation facts l.jpg

Cessation Facts

  • About 30% of patients are current smokers

  • 70% of smokers say they are “interested” in quitting

  • Only 10 to 20% plan to quit in the next month

  • About 46% of smokers try to quit in a given year

  • The majority of smokers try to quit on their own

  • Overall, self-quitters have a success rate of 2 to 5%

  • Half of all smokers eventually quit


Tobacco intervention l.jpg

Tobacco Intervention

  • 75% of health providers THINK it is a good idea

  • 10% routinely do it

    - not confident about subject

    - questionable goals

    - afraid of negative reaction from patient

    - feel patient might be offended

    - not enough reimbursement

    - not enough time


Dental intervention l.jpg

Dental Intervention

  • 33-50% of smokers report visiting a dentist

    annually

  • 40% of dentists do not routinely ask about tobacco

    use

  • 60% do not advise tobacco users to quit


Practice implications l.jpg

Practice Implications

  • Only a minority of smokers report being advised to quit by a health care provider

  • There is substantial evidence that even brief smoking cessation counseling can be effective

  • Tobacco use status assessment, documentation and intervention by RDH and/or DDS would have a huge impact on cessation efforts


Slide17 l.jpg

History of the SCI

  • 14 member task force met September 2003

  • Summit sponsored by the RWJF SCLC

  • Grant awarded in November 2003

  • A nationwide campaign designed to promote smoking cessation intervention by dental hygienists

"The advice of a dental hygienist can be a major motivation for a quit attempt by a patient who smokes.“

-- Tammi O. Byrd, RDH, ADHA President 2003-2004


Slide18 l.jpg

ADHA Tobacco Cessation Task Force

Tammi O. Byrd, RDH

Katie L. Dawson, RDH, BS

Jacquelyn L. Fried, RDH, MS

JoAnn R. Gurenlian, RDH, PhD

Kirsten Jarvi, RDH, BS

C. Austin Risbeck, RDH

Rebecca Wilder, RDH, BS, MS

Lisa M. Esparza, RDH, BS

Maria Perno Goldie, RDH, MS

Barbara Heckman, RDH, MS

Kathleen Mangskau, RDH, BS, MPA

Margaret M. Walsh, MS, Ed.D


Slide19 l.jpg

The Objective

  • Baseline and Target:

  • Increase to 50 the percentage of dental hygienists that screen their clients regarding tobacco use (rate, type and amount) by 2006.Baseline 25% in 2001 Journal of Dental Hygiene study

  • (Winter 2001)


Slide20 l.jpg

Main Elements of the SCIYear One

Educational Program:

Ask. Advise. Refer.

SCI Liaison Program:

Designate a liaison in each state

Dedicated Website:

www.askadviserefer.org


Sci year two l.jpg

SCI Year Two

  • Grant renewed November, 2004

  • SCI Project Manager, January, 2005

  • SCI Administrative Assistant

  • SCI Liaisons in-state support

  • Six state presentations


Sci year three l.jpg

SCI Year Three

  • Grant renewed November, 2005

  • SCI Project Consultant

  • SCI Administrative Assistant

  • SCI Liaison education support

  • Twelve district presentations


Slide23 l.jpg

Three Minutes or Less Can Save Lives

  • The advice of a health care professional can more

  • than double smoking cessation success rates.

  • Tobacco dependence is a chronic disease

  • that demands treatment.

  • Effective interventions have been established and

  • should be utilized with every current and former

  • tobacco user.

  • There is no other clinical practice that has more

  • impact on reducing illness, preventing death, and

  • increasing quality of life.


Slide24 l.jpg

Does patient/client now

use tobacco?

If NO:

If YES:

Did patient once

use

Is patient now willing

tobacco?

to quit?

If NO:

If YES:

If YES:

No intervention required.

If NO:

Provide appropriate

Prevent Relapse

Encourage continued

Promote motivation

to quit.

referral.

abstinence.

Ask. Advise. Refer. Systematic Approach


Ask advise refer 5 a s l.jpg

Ask. Advise. Refer. = 5 A’s

Ask

Ask. Every patient/client about tobacco use.

Advise

Assess

Assist

Advise. Every tobacco user to quit.

Arrange

Refer. Determine willingness to quit. Provide information on quitlines.

Refer to Quitlines

ADHA Smoking Cessation Initiative (SCI)


Sci protocols l.jpg

SCI Protocols

Step 1: Ask1 min

  • Systemically ask every client about tobacco use at every visit.

  • Determine if client is current, former, or never tobacco user.

  • Determine what form of tobacco is used.

  • Determine frequency of use.

  • Document tobacco use status in the dental record.


Sci protocols27 l.jpg

SCI Protocols

Step 2: Advise1 min

  • In a clear, strong, and personalized manner, urge every tobacco user to quit.

  • Tobacco users who have not succeeded in previous quit attempts should be told that most people try repeatedly (on average 3 to 8 times) before permanent quitting is achieved.

  • Employ the teachable moment: link oral findings with advice.


Sci protocols28 l.jpg

SCI Protocols

Step 3: Refer1 min

  • Asses if client is interested in quitting.

  • Assist those interested in quitting by providing information on:

    • Statewide or national quitlines, websites and local cessation programs.

  • Use proactive referral if available

    • Request written permission to fax contact information to a cessation quitline or program. Inform the client that cessation program staff will provide follow-up.

  • Document referral on dental record.

  • Use reactive referral – provide client with contact information

  • Arrangefollow-up at periodontal maintenance visit and/or schedule a phone call


What are quitlines l.jpg

What are Quitlines?

Tobacco Quitlines are

telephone-based tobacco

cessation services available in

all states and are accessed

through a new federal toll-free

number.

They provide callers with a number of services:

  • Individualized telephone counseling

  • Educational materials

  • Referrals to local programs


Refer to l.jpg

Refer to:

Current list of all state quitlines:

www.askadviserefer.org

Department of Health and Human Services Quitline:

1-800-QUITNOW (784-8669)

Information Service Website:

http://www.smokefree.gov

Web based cessation program:

http://smokefree.gov/

or

http://www.quitnet.com


Online smoking cessation assistance l.jpg

Online Smoking Cessation Assistance

  • On-line smoking cessation services now available for smokers who prefer using computers over telephones

  • Anonymity is a plus, as with telephone quitlines

  • Early studies show promising efficacy

  • www.quitnet.com

  • www.smokeclinic.com

  • www.tobaccoschool.com


Sci scripts l.jpg

SCI Scripts

If the client uses tobacco:

“How many cigarettes per day do you smoke”

“How many cigars per day do you smoke?”

“How many bowls of pipe tobacco do you use

per day?”

“How many dips of chewing tobacco do you use per day?”

“Do others in your household use tobacco?”


Sci scripts34 l.jpg

SCI Scripts

For the client who never regularly used tobacco:

“Congratulations, you have made a wise decision to protect your health.”

“Congratulations on being a non-smoker.”


Sci scripts35 l.jpg

SCI Scripts

For the client who quit using tobacco:

“Congratulations, you made a wise decision.”

“Congratulations on quitting tobacco use. We have some good programs to help you remain tobacco-free. I can give you the contact information for the program.”


Sci scripts36 l.jpg

SCI Scripts

For the client who currently uses tobacco:

“Have you thought about quitting?”

“I can help you even if you do not want to quit. Let me give you the phone number for the statewide quitline. You can receive free counseling on how to quit and remain tobacco-free.”

“Quitlines have had proven success in helping people get through the difficult stages of quitting and many people prefer to use them.”


Sci scripts37 l.jpg

SCI Scripts

More available scripts for:

  • Pregnant mothers

  • Hospitalized clients

  • Heart Attack clients

  • Parents of children and adolescents

  • Lung, head and neck cancer clients

  • Youth


Nicotine dependence l.jpg

Nicotine Dependence

  • The most powerful of all addictions to overcome

  • Nicotine acts on nicotinic acetylcholine receptors in both the central nervous system and the peripheral nervous system resulting in a physical and biologic basis for physical dependence

  • Psychological dependence

  • Habitual dependence


Neurochemical effects of nicotine l.jpg

Dopamine Pleasure

Norepinephrine Appetite Suppression

Acetylcholine Arousal, Cognitive Enhancement

Vasopressin Memory

Serotonin Mood Modulation

ß-endorphin Anxiety Reduction

Neurochemical Effects of Nicotine

Nicotine

Benowitz NL. Primary Care. 1999;26: 619.


Biology of addiction l.jpg

Biology of Addiction

  • Addictive drugs stimulate release of dopamine (brain neurotransmitter)

  • Dopamine produces feelings of pleasure

  • Pleasure reinforces repeat administration

  • Tolerance develops

  • Abrupt discontinuation leads to symptoms of withdrawal


Nicotine addiction cycle l.jpg

Nicotine use for pleasure,

enhanced performance,

mood regulation

Tolerance and physical

dependence

Nicotine use to self-

medicate withdrawal

symptoms

Nicotine abstinence produces

withdrawal symptoms

Nicotine Addiction Cycle

Benowitz NL. Med Clin North Am. 1992; 76: 423.


Unique qualities of nicotine addiction through smoking l.jpg

Cigarette is a highly engineered drug-delivery system

Inhaling produces a rapid distribution of nicotine to the brain

Drug levels peak within 10 seconds in the brain

Acute effects dissipate within minutes, causing the smoker to continue frequent dosing throughout the day

Average smoker takes 200-300 boluses to the brain per day

Easy to get, easy to use, and it is legal!

Unique Qualities of Nicotine Addiction Through Smoking


Nicotine absorption l.jpg

Primary routes: respiratory tract, buccal mucosa,

skin

Absorption is pH-dependent

Oral absorption

- mouth is acidic

- oral tobacco products buffered to increase mouth pH to 7.0-8.0

- pH-altering beverages affect absorption

Nicotine Absorption

Benowitz NL. Primary Care. 1999;26: 619.


Nicotine absorption44 l.jpg

Lung absorption: ionized & non-ionized

90% absorption across respiratory epithelium

Alkaline form irritates throat

Ionized form allows more nicotine to be dissolved

in the tar droplets

Absorbed in tar, nicotine is less irritating to throat

Nicotine Absorption

Benowitz NL. Primary Care. 1999;26: 619.


Rates of absorption l.jpg

Rates of Absorption

Benowitz NL. Primary Care. 1999;26: 619.


Nicotine withdrawal symptoms l.jpg

Constant craving of cigarettes

Insomnia

Irritability

Anxiety

Frustration

Anger

Depression

Difficulty concentrating

Restlessness

Decreased heart rate

Increased appetite

Fatigue

Nicotine Withdrawal Symptoms

Withdrawal peaks within 24-48 hours and diminishes over 1 to 3 months.


Assessing the degree of addiction l.jpg

Assessing the Degree of Addiction

  • How many cigarettes are smoked on average per day?

  • How much time typically elapses between waking and the first cigarette?

  • What is the longest period of time between cigarettes before craving?


Assessing nicotine dependence l.jpg

Assessing Nicotine Dependence

1. How soon after you wake do you smoke your first cigarette or take your first dip?

  • <30 minutes 2

  • 31 - 60 minutes 1

  • >60 minutes 0

    2. How many cigarettes per day or tins per week do you use?

  • <10 cigarettes or <1 tin 0

  • 11 - 20 cigarettes or 1 - 2 tins 1

  • 21-30 cigarettes or >2-3 tins 2

  • >30 cigarettes or > 3 tins 3

    3. Do you find it difficult to refrain from using tobacco in places where it is forbidden (e.g., movies, work, etc)?

    Yes 1

    No 0

    Scoring: 0 - 2 (LOW) 3 - 4 (MEDIUM) 5 - 6 (HIGH)


Treatment facts l.jpg

Treatment Facts

  • The efficacy of several smoking cessation therapies is well established

  • All proven treatments appear to be equally effective: quit rates are doubled

  • Early evidence suggests allowing smokers to choose treatment produces better outcomes

  • The Agency for Health Care Policy and Research (AHCPR) published updated smoking cessation guidelines in 2000 for primary care clinicians


Clinical interventions l.jpg

Clinical Interventions

  • The “5 A’s” for patients willing to make a quit attempt

  • The “5 R’s” for patients unwilling to make a quit attempt at this time

  • Relapse prevention for patients who have recently quit

  • Intensive interventions should be provided when possible

  • Health care administrators, insurers, and purchasers should institutionalize guideline findings


Pharmacotherapy l.jpg

Pharmacotherapy

  • Seven first-line FDA approved therapies reliably increase long-term smoking abstinence rates

  • All approximately double the rate of cessation when compared to placebo

  • All help with symptoms of withdrawal


Nicotine replacement therapy l.jpg

Nicotine Replacement Therapy

  • Goal is to replace nicotine from cigarettes in order to reduce or eliminate physical withdrawal symptoms

  • Pharmacokinetic properties differ but none deliver nicotine to the circulation as fast as does inhaling cigarettes

  • Effectiveness of all are broadly similar

  • Few health interventions have such overwhelming evidence of effectiveness


Plasma nicotine concentrations cigarettes versus nrt l.jpg

Plasma Nicotine ConcentrationsCigarettes versus NRT

Cigarettes

  • 1 cigarette produces rapid surge of plasma nicotine

  •  by about 25 ng/ml in minutes; declines rapidly

    NRT

  • No form achieves plasma nicotine concentrations as high as those from smoking 20 cigarettes/day

  • Does not reproduce immediate effect of smoking

Tang JL, Law M, Wald N. BMJ. 1994; 308: 22.


Nrt contraindications l.jpg

NRT Contraindications

  • No evidence of increased cardiovascular risk with NRT except with acute disease

  • Medical contraindications:

    • Immediate myocardial infarction (< 2 weeks)

    • Serious arrhythmia

    • Serious or worsening angina pectoris

    • Accelerated hypertension


Nicotine gum l.jpg

Nicotine Gum

  • Available since 1984

  • OTC 1995

  • 2 mg recommended for patients smoking less than 1 pack per day

  • 4 mg for patients smoking over 1 pack/day

  • Full dose absorbed in about 20 minutes


Efficacy of nicotine gum n 13 studies l.jpg

Efficacy of Nicotine Gum (n = 13 Studies)

Estimated

Abstinence Rate

Odds Ratio

(95%) CI

Pharmacotherapy

Placebo

(reference group)

1.0

17.1%

1.5

(1.3 - 1.8)

23.7%

Nicotine gum


Nicorette clinical use and dosing schedule l.jpg

Proper Chewing Technique

Chew slowly

Stop chewing when peppery taste occurs

Park gum

Chew gum again when peppery taste fades

Dosing Schedule

Wk 1-6 1 piece q1-2h

Wk 7-9 1 piece q2-4h

Wk 10-12 1 piece q4-8h

Max dose: 24 pieces/day

Nicorette®Clinical use and Dosing Schedule


Nicotine patch l.jpg

Nicotine Patch

  • Available since 1994

  • OTC 1996

  • 21 mg recommended for patients smoking 1 pack per day

  • 14 mg for patients smoking 1/2 pack/day

  • 7 mg for patients smoking 5 or less cigarettes a day

  • Full dose absorbed in about 2 hours


Efficacy of nicotine patch n 27 studies l.jpg

Efficacy of Nicotine Patch (n = 27 Studies)

Odds Ratio

(95%) CI

Estimated

Abstinence Rate

Pharmacotherapy

Placebo

(reference group)

1.0

10.0%

1.9

(1.7 - 2.2)

17.7%

Nicotine patch


Nicotine transdermal patches dosing l.jpg

Nicotine Transdermal PatchesDosing


Nicotine inhaler l.jpg

Nicotine Inhaler

  • Available since 1998 - Rx

  • Each cartridge delivers 4 mg of nicotine over 80 inhalations

  • Full dose absorbed in about 20 minutes

  • Designed to combine pharmacological and behavioral substitution


Nicotine inhaler62 l.jpg

Nicotine is absorbed through buccal membrane

Satisfies hand-to-mouth ritual of smoking

Two-fold increase in quit rates at 12 months

Dosage

Initial treatment

6 cartridges/day increase prn to max 16 cartridges/day

min of 3 weeks, up to 12 weeks or longer as needed

Gradual dosage reduction

if needed over additional 12 weeks

Nicotine Inhaler


Schematic of the nicotine inhaler l.jpg

Schematic of the Nicotine Inhaler

Sharp point that

breaks the seal

Cartridge

Air/Nicotine

Mixture Out

Sharp point that

breaks the seal

Mouthpiece

Air In

Porous Plug Impregnated with Nicotine

Aluminum Laminate

Sealing Material


Efficacy of nicotine inhaler n 4 studies l.jpg

Efficacy of Nicotine Inhaler (n = 4 Studies)

Odds Ratio

(95%) CI

Estimated

Abstinence Rate

Pharmacotherapy

Placebo

(reference group)

1.0

10.5%

2.5

(1.7 - 3.6)

22.8%

Nicotine inhaler


Nicotine nasal spray l.jpg

Nicotine Nasal Spray

  • Available since 1996 - Rx

  • Each spray delivers 0.5 mg of nicotine

  • Full dose absorbed in less than 3 minutes

  • Minimum recommended treatment is 8 doses per day


Nicotine nasal spray dosage and pharmacokinetics l.jpg

Nicotine Nasal SprayDosage and Pharmacokinetics

  • Dosage: 1-2 sprays in each nostril every hour for 6-8 wks

    • 1mg (1 dose) = 1 spray in each nostril

    • max dose: 40 doses/day or 5 doses/hr

  • Pharmacokinetics

    • 1/2 - 2/3 of dose absorbed systemically

    • time to peak: 3-15 minutes

    • absorption is decreased with colds or rhinitis


Nicotine nasal spray nicotrol ns l.jpg

Nicotine Nasal SprayNicotrol NS®

  • Metered dose pump 10mg/ml 10ml (200 sprays)

  • Designed for quick delivery of nicotine

  • Similar efficacy to patches and gum

  • May be most beneficial to highly dependant smokers


Efficacy of nicotine nasal spray n 3 studies l.jpg

Efficacy of Nicotine Nasal Spray (n = 3 Studies)

Odds Ratio

(95%) CI

Estimated

Abstinence Rate

Pharmacotherapy

Placebo

(reference group)

1.0

13.9%

2.7

(1.8 - 4.1)

30.5%

Nicotine nasal

spray


Nicotine lozenge l.jpg

Nicotine Lozenge

  • Available since 2002 - OTC

  • 2 mg recommended for patients who smoke more than 30 minutes after waking

  • 4 mg for patients who smoke within 30 minutes of waking

  • Full dose absorbed in about 20 minutes


Nicotine lozenge70 l.jpg

Nicotine Lozenge

  • Oral NRT

  • Like hard candy, dissolves in mouth

  • One lozenge every 1-2 hours for the first six weeks; one lozenge every 2-4 hours during weeks 7-9; one lozenge every 4-8 hours during the final weeks 10-12.


Combination nicotine replacement therapy l.jpg

Combination Nicotine Replacement Therapy

  • Combining the nicotine patch and a self-administered NRT (either nicotine gum or nicotine nasal spray) is more efficacious than a single form of NRT


Slide72 l.jpg

30

25

20

Plasma nicotine (ng/mL)

15

10

5

0

0

10

20

30

40

50

60

Minutes

NICOTINE DELIVERY SYSTEMS:PLASMA CONCENTRATIONS

Cigarette

Gum (4 mg)

Gum (2 mg)

Inhaler

Nasal spray

Patch

Reprinted with permissionfrom Schneider et al., Clinical Pharmacokinetics 2001;40(9):661–684. Adis International, Inc.


Non nicotine medications bupropion l.jpg

Non-Nicotine MedicationsBupropion

  • An atypical antidepressant with dopaminergic and noradrenergic activity

  • First FDA approved non-NRT

  • Risk of seizure is 0.1% or less

  • Can be used in combination with NRT

  • Is effective in those with no current or past depressive symptoms


Bupropion sr l.jpg

Bupropion SR

  • Available by prescription only (USA)

  • Dosing:

    • Start 1-2 weeks before quit date

    • 150 mg orally once daily x 3 day

    • 150 mg orally twice daily x 7-12 weeks

    • No taper necessary at end of treatment

  • Maintenance: consider as a maintenance therapy for up to 6 months post-cessation


Efficacy of bupropion sr n 2 studies l.jpg

Efficacy of Bupropion SR (n = 2 Studies)

Estimated

Abstinence Rate

Odds Ratio

(95%) CI

Pharmacotherapy

Placebo

(reference group)

1.0

17.3%

2.1

(1.5 - 3.0)

30.5%

Bupropion SR


Dose response trial l.jpg

Dose-Response Trial


Comparative trial l.jpg

Comparative Trial


Slide78 l.jpg

6-MONTH QUIT RATES

(Minimal Contact)

Data adapted from Hughes et al. JAMA 1999;281:72–76.


Multiple pharmacotherapy l.jpg

Multiple Pharmacotherapy

  • Bupropion SR may be combined with any of the NRTs

  • Combination NRT

    • Patch + gum or patch + nasal spray is more efficacious than a single NRT

    • Encourage in patients unable to quit using single agent

    • Combined NRT not currently FDA approved


Non nicotine medications varenicline l.jpg

Non-Nicotine MedicationsVarenicline

  • A partial nicotinic acetylcholine receptor agonist

  • Specifically indicated for use as an aid in smoking cessation

  • Provides some nicotine effects to ease withdrawal symptoms

  • Blocks effects of nicotine


Varenicline chantix l.jpg

Varenicline (Chantix)

Recommended dosage:

  • Start 1 week before quit date

  • 0.5 mg for 3 days

  • Then 0.5 mg BID for 4 days

  • Then 1 mg BID for up to 12 weeks


Varenicline chantix82 l.jpg

Varenicline (Chantix)

Efficacy:

  • Six clinical trials N=3659

  • Self-report verified by CO measurement

  • 1 in 5 quit at 1 year

    Precautions:

  • Nausea reported by 1/3

  • Pregnancy Category C

    NO Contraindications


Pharmacotherapy for light smokers l.jpg

Pharmacotherapy for Light Smokers

  • Consider reducing dose of first-line pharmacotherapies

  • Bupropion SR may be prescribed at full strength


Extended use of pharmacotherapy l.jpg

Extended Use of Pharmacotherapy

  • First-line tobacco dependence medications may be considered for extended use, especially in patients with persistent withdrawal symptoms

  • Evidence shows that a minority of patients continue ad libitum NRT agents

  • Does not present known health risks

  • FDA has approved bupropion SR for a long-term maintenance indication


Psychosocial therapies l.jpg

Psychosocial Therapies

  • Behavioral therapy is the only proven psychosocial treatment for smoking cessation

  • Usually administered in a group setting

  • Can also be conducted on an individual basis

  • Major disadvantage is limited availability and acceptability


Alternative therapies l.jpg

Alternative Therapies

  • Acupuncture

  • Hypnosis

  • Massage

  • Laser


Ahcpr guidelines l.jpg

AHCPR Guidelines

  • Ask every patient at every visit if he or she smokes

  • Record patients’ smoking status with vital signs

  • Ask patients about their desire to quit

  • Motivate patients who are reluctant to quit

  • Help motivated smokers to set a quit date

  • Prescribe nicotine replacement therapy

  • Help patients resolve problems from quitting

  • Encourage relapsed smokers to try quitting again


Ahcpr guidelines88 l.jpg

AHCPR Guidelines

  • Documenting tobacco use status at every clinic visit will increase rates of clinician intervention and can increase abstinence rates

  • Identification guides effective and appropriate intervention based on patient’s tobacco use status and willingness to quit


Vital signs stamp l.jpg

Vital Signs Stamp

VITAL SIGNS

Blood Pressure:

Pulse:

Weight:

Temperature:

Respiratory Rate:

Tobacco Use:

CurrentFormerNever

(circle one)


Elements of a counseling intervention l.jpg

Quit date:

Set a stop date, preferably within 2 weeks

Starting on the quit date, total abstinence is essential

Past quit experience:

Identify what helped and what hurt in previous quit attempts

Anticipate triggers or challenges in upcoming attempt:

Discuss challenges/triggers and how patient will successfully overcome them

Elements of a Counseling Intervention


Elements of a counseling intervention cont d l.jpg

Elements of a Counseling Intervention (cont’d)

  • Alcohol:

    • Since alcohol can cause relapse, the patient should consider limiting/abstaining from alcohol while quitting

  • Other smokers in the household:

    • Quitting is more difficult when there is another smoker in the household

    • Patients should encourage housemates to quit with them or not smoke in their presence


Five a s l.jpg

Five A’s

  • Ask - initial step is to identify if client uses tobacco

  • Advise - deliver clear, strong, personal, and straightforward advice about the importance of quitting; emphasize four R's: risks, relevance, rewards, repetition

  • Assess - willingness to make a quit attempt

  • Assist - set quit date, offer pharmacologic and behavioral support

  • Arrange - follow-up to prevent relapse


The five a s of a three minute intervention continued l.jpg

The Five “A”s of a Three-Minute Intervention (continued)

  • Ask about tobacco use

  • Every patient on every visit

  • Past/present tobacco use

  • Smoking as a vital sign

  • WT_____HT_____BP_____TEMP_____P_____

  • Tobacco Use: Current Former Never

WT_____HT_____ BP______ TEMP______P______

CC: ________________________________________

Tobacco Use (circle): Current Former Never

Fiore MC, Bailey WC, Cohen SJ, et al. Treating Tobacco Use and Dependence. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service. June 2000. Page 28.


The five a s of a three minute intervention continued94 l.jpg

Advise patient to quit

Stress importance of quitting

Personalize advice

Example: “This is the third time you have had bronchitis this year. Your smoking is affecting your health.”

Deliver strong, firm message

Example: “Quitting smoking is the best way to reduce your health risk.”

The Five “A”s of a Three-Minute Intervention (continued)

Fiore MC, Bailey WC, Cohen SJ, et al. Treating Tobacco Use and Dependence. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service. June 2000. Page 28.


The five a s of a three minute intervention continued95 l.jpg

Assess willingness to make quit attempt now, e.g., within next 30 days

“On a scale of 1 to 10, how motivated are you?”

If patient is willing to quit

Provide assistance

Offer intensive treatment or refer patient

If patient is unwilling to quit

Provide motivational intervention

Relevance, risks, rewards, roadblocks and repetition

Special populations (adolescents, pregnant smokers)

The Five “A”s of a Three-Minute Intervention (continued)

Fiore MC, Bailey WC, Cohen SJ, et al. Treating Tobacco Use and Dependence. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service. June 2000. Page 29.


The five a s of a three minute intervention continued96 l.jpg

Assist by helping patient formulate quit plan

Set quit date within 2 weeks

Tell family and friends for support

Anticipate challenges

Withdrawal during first few weeks

Remove all tobacco products and alcohol from environment

The Five “A”s of a Three-Minute Intervention (continued)

Fiore MC, Bailey WC, Cohen SJ, et al. Treating Tobacco Use and Dependence. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service. June 2000. Page 29.


The five a s of a three minute intervention continued97 l.jpg

Arrange follow-up contact (in person/by phone)

Timing

Preferably during first week

Second follow-up contact within first month

Actions during follow-up contact

Congratulate success

Assess pharmacotherapy use; consider more intensive treatment

If tobacco use has occurred, review circumstances and elicit recommitment to total abstinence

Remind patient a lapse can be a learning experience

The Five “A”s of a Three-Minute Intervention (continued)

Fiore MC, Bailey WC, Cohen SJ, et al. Treating Tobacco Use and Dependence. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service. June 2000. Page 31.


The 5 r s to enhance motivation for patients unwilling to quit l.jpg

The “5 R’s” to Enhance Motivation for Patients Unwilling To Quit

  • RELEVANCE: Tailor advice and discussion to each patient

  • RISKS: Discuss risks of continued smoking

  • REWARDS: Discuss benefits of quitting

  • ROADBLOCKS: Identify barriers to quitting

  • REPETITION: Reinforce the motivational message at every visit


Stages of change l.jpg

Stages of Change

  • Precontemplative (not ready to consider quitting)

  • Contemplative (planning to quit in next 6 months, no stop date set, ambivalent)

  • Preparation (planning to quit, stop date set)

  • Action (has quit)

  • Maintenance (has not used for more than 6 months)

  • Termination (no longer any serious temptation)


Precontemplation l.jpg

Precontemplation

  • Employ consciousness-raising to help the smoker to think of quitting in next six months

  • Discuss smoker’s feelings about the idea of quitting

  • Review advantages of quitting/inconveniences of smoking

  • Counsel about risks of smoking

  • Adapt message to suit the beliefs, knowledge, and attitudes of the smoker


Contemplation l.jpg

Contemplation

  • Assure that advantages of quitting will be more significant than inconveniences

  • Offer confidence that the smoker can do it

  • Identify obstacles in quitting and explore solutions

  • Encourage the smoker to picture life as an ex-smoker

  • Reinforce the reasons given by the smoker to change


Preparation l.jpg

Preparation

  • Ask smoker to set quit date

  • Explore the possible behavioral substitutes

  • Discuss the strategies and available resources

  • Help smoker to decide on a plan of action

  • Encourage observation of smoking behavior in order to be aware of patterns/vulnerable times

  • Motivate smoker as the planning takes place


Action l.jpg

Action

  • Support the smoker and the actions taken for change

  • Discuss any relapses and develop plan to deal with relapses as necessary

  • Ask questions about triggers

  • Strongly suggest to the smoker to keep on using strategies for at least three months

  • Refer to group program or support group as needed

  • As necessary, revise therapies


Maintenance l.jpg

Maintenance

  • Help to recognize and use strategies to prevent relapses

  • Reevaluate the strategies based on smoker’s knowledge, behavior and modify as needed

  • Reinforce reasons for quitting

  • Reinforce self confidence in quitting

  • Encourage rewards!

  • Reinforce decision to quit - commitment!


Termination l.jpg

Termination

  • Most smokers say this never really occurs - desire for a cigarette never disappears

  • Maintenance becomes less vigilant over time

  • Withdrawal is manageable

  • No longer any serious temptation


Relapse considerations l.jpg

Relapse Considerations

  • Encourage quit attempt as soon as possible after relapse

  • Adequacy of nicotine replacement therapy dosage

  • Length of treatment

  • Follow up contact is vital

  • Relapse rates are highest during first few days of cessation

  • Referral to smoking cessation specialist after 2 to 3 relapses


Preventing relapse l.jpg

Preventing Relapse

  • Relapse prevention interventions should be provided with every smoker who has recently quit

  • Crucial to address relapse the first 3 months after quitting

  • Strategies to use with recent quitters:

    • Encourage continued abstinence

    • Invite discussion of benefits, success milestones, problems encountered or anticipated

    • Use or refer to an intensive intervention as appropriate


Ambivalence l.jpg

Ambivalence

Patient’s task to articulate and resolve ambivalence.

Clinician’s role to help him/her examine and resolve ambivalence.


Special populations l.jpg

Special Populations

  • In general, treatments found to be effective in the guideline should be used with all populations

  • Some special populations may have concerns that can be addressed within the context of treatment:

    • Women

    • Racial and ethnic minorities

    • Adolescents

    • Older smokers


Pregnant smokers l.jpg

Pregnant Smokers

  • Augmented interventions approximately doubles abstinence rates relative to usual care

  • Greatest health benefits result from cessation early in pregnancy, however, pregnant women should be encouraged to quit anytime during pregnancy

  • Pharmacotherapy should be considered when a pregnant woman is otherwise unable to quit, and when the likelihood of quitting, with its potential benefits, outweighs the risks of the pharmacotherapy and potential continued smoking


Smokers with comorbidities l.jpg

Smokers with Comorbidities

  • Smokers with a psychiatric comorbidity or chemical dependency should be offered guideline-based treatments:

    • Psychiatric disorders are more common in smokers than the general population and carry a higher rate of relapse

    • Bupropion SR or nortriptyline should be considered in smokers with a history of depression

    • Smoking cessation does not appear to interfere with recovery from chemical dependency


Weight gain l.jpg

Weight Gain

  • Clinicians should openly address postcessation weight gain concerns:

    • Acknowledge weight gain is likely but typically limited

    • Encourage concentration on smoking cessation now, weight control later

    • Recommend healthy diet and physical activity

    • Consider pharmacotherapy, particularly bupropion SR and nicotine gum, shown to delay (but not prevent) weight gain


Non cigarette tobacco users l.jpg

Non-Cigarette Tobacco Users

  • Smokeless/spit tobacco users can be treated successfully using counseling treatments found to be effective in the guideline

  • Brief interventions in a dental setting can effectively treat smokeless/spit tobacco users

  • Users of smokeless/spit tobacco, cigars, pipes should be identified and offered treatment


Metabolic effects l.jpg

Potentiates Metabolism of:

Beta-blockers

Insulin

Caffeine

Adrenergic antagonists

Acetaminophen

Oxazepam (Serax)

Imipramine (Tofranil)

Propoxyphene napsylate

(Davocet, Darvon)

Theophylline

Antagonizes Metabolism of:

Adrenergic agonists

Metabolic Effects


Coding for treatment of tobacco use and dependence l.jpg

Coding for Treatment of Tobacco Use and Dependence

Record:

ADA Code 1320 – Tobacco Counseling for the Control and Prevention of Oral Disease


Program agenda l.jpg

Session 1

Session 2

Session 3

Session 4

Orientation & Introductions

Understanding addiction

Preparation_________________

Benefits of Quitting

Withdrawal Symptoms

Cessation Strategies__________

QUIT DAY_________________

Motivation Reinforcement

Support Systems

Program Agenda


Program agenda117 l.jpg

Session 5

Session 6

Session 7

Session 8

Lifestyle issues:

Nutrition/Weight

Exercise____________________

Stress Management

Relaxation Skills

New Self-image______________

Ex-smokers panel_____________

Graduation & Celebration

Relapse Prevention

Program Agenda


Power of intervention l.jpg

Power of Intervention

  • The costs of providing brief interventions is $3 per smoker

  • Implementing such interventions could quadruple the national annual cessation rate, translating to roughly 4.8 million quitters

  • Adding brief behavioral counseling and medication can increase the cessation rate sixfold, translating to roughly 7.2 million quitters


The benefits of quitting smoking l.jpg

The Benefits Of Quitting Smoking

  • At 1 year excess risk of coronary heart disease decreases to half that of a smoker

  • At 5 years stroke risk reduces to that of people who have never smoked


The benefits of quitting smoking120 l.jpg

The Benefits Of Quitting Smoking

  • At 10 years the risk of lung cancer drops to one-half that of continuing smokers

  • At 15 years the risk of coronary heart disease is now similar to that of people who have never smoked and the risk of death returns to nearly the level of people who have never smoked


The benefits of quitting smoking121 l.jpg

The Benefits Of Quitting Smoking

  • Children in households will be less likely to become smokers once their parents quit. All family members will be exposed to less second-hand smoke.

  • Former pack-a-day smokers save about $120-190 a month.


Benefits of quitting l.jpg

Benefits of Quitting

  • Mortality ratios for oral cancer diminish

  • Premalignant lesions may regress after the discontinuation of smoking or stopping smokeless tobacco use

  • Decreases the risk of second or multiple primary tumors in patients with a previous cancer of the oral cavity or pharynx

Martin et al. 1999


Why dental hygienists l.jpg

Why Dental Hygienists?

  • Have interviewing skills.

  • Have educating skills.

  • Have motivating skills.

  • Have counseling skills.

  • Dental hygiene is the most frequently provided service.

  • Follow-up procedures have always been an important part of the dental hygiene practice.


Systems changes l.jpg

Systems Changes

  • Can reduce smoking prevalence.

  • Makes it easier for dental hygienists to help tobacco users quit.

  • Requires changes in the systems in the profession and in the dental office.

  • A simplified approach is more likely to lead to successful interventions.

  • A simplified approach opens the door to more intensive interventions.


Systems changes in the dental office l.jpg

Systems Changes in the Dental Office

A system in the office can be brief, simple and does not need to disrupt the practice routine.

  • Organize the team and assign team duties and responsibilities.

  • Implement an office-wide tobacco user identification system.

  • Identify and track tobacco use status.

  • Refer tobacco users to a quitline.


Program responsibilities l.jpg

Program Responsibilities

Dentist: Program Director

ADVISE to quit, prescribe pharmacotherapy.

Dental Hygienist: Program Coordinator

Determine willingness to quit, REFER to quitline. Track tobacco use status.

Dental Assistant

Assist front office making follow-up calls concerning quit dates.

Front Office

Update health history and ASK about tobacco use status. Telephone patient/client just before and soon after quit date.


Make it a priority l.jpg

Make it a Priority!

  • Single most effective step to lengthen and improve patients’ lives

  • Quitting smoking has immediate and long-term benefits and is well worth the difficulty, both for patient and clinician

  • The health care system’s neglect of the tobacco user exacts costs that sum to thousands of lives and billions of dollars in added health care expenditures


In summary l.jpg

In Summary

  • Brief tobacco dependence treatment is effective and every patient who uses tobacco should be identified, urged to quit, and offered at least one of these treatments:

    • Patients willing to quit should be provided treatments identified as effective

    • Patients unwilling to quit should be provided an intervention to increase their motivation to quit


Conclusions l.jpg

Conclusions

  • Nicotine dependence is a chronic condition

  • Every patient who uses tobacco should be offered treatment

  • It is essential that clinicians and health care delivery systems institutionalize the consistent identification, documentation and treatment of every tobacco user

  • Brief tobacco dependence treatment is effective

  • There is a strong dose-response relationship between the intensity of tobacco dependence counseling and its effectiveness

  • Numerous effective pharmacotherapies now exist

  • Tobacco dependence treatments are both clinically effective and cost-effective relative to other medical and disease-prevention interventions


Slide130 l.jpg

“Lives saved from smoking cessation would swamp all the benefits accrued if each year every person underwent every cancer screening procedure recommended by the American Cancer Society.”–

Steven A. Schroeder, MD

Medical Director

Smoking Cessation Leadership Center


Slide131 l.jpg

Health professionals shouldn’t grade themselves on how many people they can “get” to quit, but rather how many times they give the messagewhen the opportunity arises.

Under these criteria, there is no reason not to have an intervention success approaching 100%


About the adha website l.jpg

About the ADHA Website

www.askadviserefer.org

Available to download for all dental hygienists and their clients:

  • Protocols & Scripts Document

  • PowerPoint Presentations

  • Fact Sheets (for the Consumer & the Dental Hygiene Professional)

  • Ask. Advise. Refer. Flyer

  • Liaison Resource List

  • Quitline Resource List

  • Relevant State & National News and Announcements


Resources l.jpg

Resources

  • www.tobacco.org

  • http://www.ctcinfo.org The Center for Tobacco Cessation

  • www.umassmed.edu/behavmed/tobacco/

  • Addressing Tobacco in Managed Carewww.atmc.wisc.edu

  • www.cdc.gov/tobacco

  • http://www.smokefree.gov NCI site


Surgeon general s web site l.jpg

Surgeon General’s Web site

  • The full text of the guideline documents and the meta-analyses references for online retrieval are available at:

    www.surgeongeneral.gov/tobacco/default.htm

  • The Clinical Practice Guideline

  • The Quick Reference Guide

  • Consumer Versions


Adha s sci project consultant l.jpg

ADHA’s SCI Project Consultant

Carol Southard, RN MSN

Smoking Cessation Initiative Project Consultant

American Dental Hygienists' Association

444 N. Michigan Ave., Suite 3400

Chicago, IL 60611

1-800-243-ADHA, ext. 220

E-mail: [email protected]


References l.jpg

References

  • Clinical Practice Guideline Panel and Staff, A Clinical Guideline for Treating Tobacco Use and Dependence. JAMA, 283, 3244-54, 2000.

  • Fiore MC, Bailey WC, Cohen SJ, et al. Treating tobacco use and dependence. Rockville, MD.: Department of Health and Human Services, Public Health Service, 2000.

  • Hughes, JR. New treatments for smoking cessation. Cancer Journal for Clinicians 2000; 50: 143-155.

  • Lancaster T, Stead L, Silagy C, Sowden A. Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library. BMJ 2000; 321: 355-8.

  • Rigotti, N. Treatment of tobacco use and dependence. New England Journal of Medicine 2002; 346: 506-512.

  • US Department of Health and Human Services, Clinical Practice Guideline: Treating Tobacco Use and Dependence. US Department of Health and Human Services, Public Health Service, June 2000.

  • US Department of Health and Human Services. The Surgeon General’s Report on The Health Consequences of Smoking. US Department of Health and Human Services, Public Health Service, 2004.


  • Login